March 6 Practice & Trends On The Cover Community pharmacists prescribe and dispense Paxlovid despite hurdles PT March 2023 Every at-home COVID-19 test that leaves Moose Pharmacy in Charlotte, NC, carries a sticker bearing a QR code. Beside the code, the text reads, “Test POSITIVE for COVID-19?"
March 7 Drugs & Diseases OTCs Today Sleep aids to the rescue? PT March 2023 According to CDC, 8.4% of adults took sleep medication either every day or most days to help them fall or stay asleep in 2020. Mary Warner
March 7 Drugs & Diseases On The Shelf SAMe: The same old, same old? PT March 2023 S-adenosyl-l-methionine (SAMe) is a compound found naturally in the body, produced in the liver. Mickie Cathers
March 7 Drugs & Diseases New Drug Breathing easy with Airsupra PT March 2023 For years, patients with asthma have been prescribed regimens that include several different inhalers, requiring them to remember the correct timing and situation for using each one. Lauren Howell, PharmD
March 7 Drugs & Diseases Fentanyl Fentanyl-based OUD guidance needed in light of crisis PT March 2023 The latest CDC data find that deaths involving synthetic opioids like fentanyl increased by a staggering 80% over the past 2 years. These drugs were involved in more than two-thirds of the overdose deaths in the year ending March 2022. Loren Bonner
March 7 Drugs & Diseases Gabapentin Overlapping gabapentin and opioid prescriptions have been on the rise PT March 2023 Ninety-five percent of gabapentin prescriptions are written for off-label pain management, despite studies questioning gabapentin’s effectiveness for managing pain, and reports of its misuse with simultaneous opioid therapy. Loren Bonner
March 7 Drugs & Diseases Antithrombotics Interruption or continuation of antithrombotic therapy in perioperative patients? PT March 2023 Too often, clinicians question whether they are making the right decision about a patient’s anticoagulation therapy with planned, nonemergent surgical procedures. Ariel L. Clark, PharmD
March 7 Practice & Trends Diabetes GLP-1 receptor agonists: Breaking down the hype and demand PT March 2023 For pharmacists like Candis Morello who are treating patients using GLP-1 receptor agonists, it’s been a challenging few months navigating the shortage of this class of medications.
March 7 Practice & Trends Pharmacy Techs Win–win: Permanent PREP Act declarations benefit pharmacy staff, patients, and more PT March 2023 The value in expansion and protection of pharmacy technicians’ capabilities provided by the ninth amendment to the PREP Act has been incalculable in the face of the COVID-19 pandemic.